China National Medicines Corporation Ltd. (600511.SS)
CNY 34.43
(1.89%)
CNY 34.43
(1.89%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 3.15 Billion CNY | 512.98% |
| 2022 | 515.12 Million CNY | -27.79% |
| 2021 | 713.33 Million CNY | -11.06% |
| 2020 | 802.04 Million CNY | 43.8% |
| 2019 | 557.74 Million CNY | -45.6% |
| 2018 | 1.02 Billion CNY | -17.08% |
| 2017 | 1.23 Billion CNY | -47.66% |
| 2016 | 2.36 Billion CNY | 687.34% |
| 2015 | 300 Million CNY | -25.0% |
| 2014 | 400 Million CNY | 0.0% |
| 2013 | 400 Million CNY | 166.67% |
| 2012 | 150 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | -100.0% |
| 2009 | 18.71 Million CNY | 298.77% |
| 2008 | 4.69 Million CNY | -96.44% |
| 2007 | 132.01 Million CNY | -5.71% |
| 2006 | 140 Million CNY | 15.51% |
| 2005 | 121.19 Million CNY | -21.1% |
| 2004 | 153.61 Million CNY | 21.34% |
| 2003 | 126.6 Million CNY | 33.35% |
| 2002 | 94.94 Million CNY | 74.71% |
| 2001 | 54.34 Million CNY | -12.83% |
| 2000 | 62.34 Million CNY | -29.43% |
| 1999 | 88.34 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 284.32 Million CNY | -82.23% |
| 2024 Q1 | 545.66 Million CNY | -82.72% |
| 2024 Q2 | 3.24 Billion CNY | 494.77% |
| 2023 Q1 | 494.98 Million CNY | -3.91% |
| 2023 Q3 | 428.12 Million CNY | -4.96% |
| 2023 Q4 | 3.15 Billion CNY | 637.56% |
| 2023 FY | 3.15 Billion CNY | 512.98% |
| 2023 Q2 | 450.46 Million CNY | -8.99% |
| 2022 Q2 | 581.95 Million CNY | 42.42% |
| 2022 FY | 515.12 Million CNY | -27.79% |
| 2022 Q4 | 515.12 Million CNY | -13.77% |
| 2022 Q3 | 597.41 Million CNY | 2.66% |
| 2022 Q1 | 408.61 Million CNY | -42.72% |
| 2021 Q2 | 773.29 Million CNY | -6.51% |
| 2021 Q4 | 713.33 Million CNY | -16.54% |
| 2021 FY | 713.33 Million CNY | -11.06% |
| 2021 Q3 | 854.7 Million CNY | 10.53% |
| 2021 Q1 | 827.15 Million CNY | 3.13% |
| 2020 Q4 | 802.04 Million CNY | -9.73% |
| 2020 FY | 802.04 Million CNY | 43.8% |
| 2020 Q1 | 1.22 Billion CNY | 118.77% |
| 2020 Q2 | 1.05 Billion CNY | -13.86% |
| 2020 Q3 | 888.53 Million CNY | -15.47% |
| 2019 FY | 557.74 Million CNY | -45.6% |
| 2019 Q1 | 1.09 Billion CNY | 6.5% |
| 2019 Q2 | 722.75 Million CNY | -33.81% |
| 2019 Q4 | 557.74 Million CNY | -19.96% |
| 2019 Q3 | 696.82 Million CNY | -3.59% |
| 2018 Q3 | 655.04 Million CNY | -50.35% |
| 2018 FY | 1.02 Billion CNY | -17.08% |
| 2018 Q1 | 1.71 Billion CNY | 38.37% |
| 2018 Q2 | 1.31 Billion CNY | -22.87% |
| 2018 Q4 | 1.02 Billion CNY | 56.52% |
| 2017 Q2 | 1.48 Billion CNY | 0.0% |
| 2017 FY | 1.23 Billion CNY | -47.66% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q4 | 1.23 Billion CNY | -9.06% |
| 2017 Q3 | 1.35 Billion CNY | -8.23% |
| 2016 Q1 | 100 Million CNY | -66.67% |
| 2016 Q2 | 100 Million CNY | 0.0% |
| 2016 Q3 | - CNY | -100.0% |
| 2016 FY | 2.36 Billion CNY | 687.34% |
| 2016 Q4 | 646.28 Million CNY | 0.0% |
| 2015 Q2 | 400 Million CNY | 0.0% |
| 2015 Q1 | 400 Million CNY | 0.0% |
| 2015 FY | 300 Million CNY | -25.0% |
| 2015 Q4 | 300 Million CNY | -25.0% |
| 2015 Q3 | 400 Million CNY | 0.0% |
| 2014 Q4 | 400 Million CNY | -11.11% |
| 2014 Q1 | 450 Million CNY | 12.5% |
| 2014 Q2 | 450 Million CNY | 0.0% |
| 2014 Q3 | 450 Million CNY | 0.0% |
| 2014 FY | 400 Million CNY | 0.0% |
| 2013 Q4 | 400 Million CNY | 14.29% |
| 2013 FY | 400 Million CNY | 166.67% |
| 2013 Q1 | 150 Million CNY | 0.0% |
| 2013 Q2 | 250 Million CNY | 66.67% |
| 2013 Q3 | 350 Million CNY | 40.0% |
| 2012 FY | 150 Million CNY | 0.0% |
| 2012 Q1 | 200 Million CNY | 0.0% |
| 2012 Q3 | 115.9 Million CNY | -53.64% |
| 2012 Q2 | 250 Million CNY | 25.0% |
| 2012 Q4 | 150 Million CNY | 29.42% |
| 2011 FY | - CNY | 0.0% |
| 2011 Q4 | - CNY | 0.0% |
| 2011 Q3 | - CNY | 0.0% |
| 2011 Q1 | - CNY | 0.0% |
| 2011 Q2 | - CNY | 0.0% |
| 2010 Q4 | - CNY | 0.0% |
| 2010 Q2 | - CNY | -100.0% |
| 2010 Q1 | 11.17 Million CNY | -40.3% |
| 2010 FY | - CNY | -100.0% |
| 2010 Q3 | - CNY | 0.0% |
| 2009 FY | 18.71 Million CNY | 298.77% |
| 2009 Q4 | 18.71 Million CNY | 380.79% |
| 2009 Q3 | 3.89 Million CNY | -19.92% |
| 2009 Q2 | 4.86 Million CNY | -14.83% |
| 2009 Q1 | 5.7 Million CNY | 21.61% |
| 2008 Q3 | 38.13 Million CNY | -72.76% |
| 2008 FY | 4.69 Million CNY | -96.44% |
| 2008 Q4 | 4.69 Million CNY | -87.69% |
| 2008 Q1 | 191.25 Million CNY | 44.88% |
| 2008 Q2 | 140 Million CNY | -26.8% |
| 2007 Q4 | 132.01 Million CNY | 15859.0% |
| 2007 FY | 132.01 Million CNY | -5.71% |
| 2007 Q3 | 827.19 Thousand CNY | -66.19% |
| 2007 Q1 | 84.44 Million CNY | -39.68% |
| 2007 Q2 | 2.44 Million CNY | -97.1% |
| 2006 Q2 | 69 Million CNY | -32.35% |
| 2006 Q4 | 140 Million CNY | 102.9% |
| 2006 Q3 | 69 Million CNY | 0.0% |
| 2006 FY | 140 Million CNY | 15.51% |
| 2006 Q1 | 102 Million CNY | -15.84% |
| 2005 FY | 121.19 Million CNY | -21.1% |
| 2005 Q4 | 121.19 Million CNY | -23.77% |
| 2005 Q1 | 197.68 Million CNY | 28.69% |
| 2005 Q2 | 148.45 Million CNY | -24.9% |
| 2005 Q3 | 159 Million CNY | 7.1% |
| 2004 Q2 | 81 Million CNY | -36.02% |
| 2004 Q4 | 153.61 Million CNY | 38.39% |
| 2004 Q3 | 111 Million CNY | 37.04% |
| 2004 Q1 | 126.6 Million CNY | 0.0% |
| 2004 FY | 153.61 Million CNY | 21.34% |
| 2003 Q1 | 79.94 Million CNY | -15.8% |
| 2003 FY | 126.6 Million CNY | 33.35% |
| 2003 Q2 | 111.6 Million CNY | 39.6% |
| 2003 Q3 | 111.6 Million CNY | 0.0% |
| 2003 Q4 | 126.6 Million CNY | 13.44% |
| 2002 Q2 | 67.34 Million CNY | 0.0% |
| 2002 FY | 94.94 Million CNY | 74.71% |
| 2002 Q4 | 94.94 Million CNY | 0.0% |
| 2001 FY | 54.34 Million CNY | -12.83% |
| 2000 FY | 62.34 Million CNY | -29.43% |
| 1999 FY | 88.34 Million CNY | 0.0% |